Model
Edge
Telomir Pharmaceuticals Inc.
0001971532
Filing Type
8-K
Filing Date
4/23/2026
Updated
4/24/26, 7:25 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities
EX-10.1
EX-10.1